{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:50:01Z","timestamp":1794635401005,"version":"4.9.1"},"reference-count":113,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MR\/R005885\/1"],"award-info":[{"award-number":["MR\/R005885\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Education, Taiwan"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Preclinical animal and preliminary human studies indicate that 5-HT7 antagonists have the potential as a new treatment approach for mood and anxiety disorders. In this systematic review, we aimed to review the relationship between the 5-HT7 receptor system and mood and anxiety disorders, and to explore the pharmacology and therapeutic potential of medications that target the 5-HT7 receptor for their treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Medline, Cochrane Library, EMBASE, PsycINFO databases, the National Institute of Health website Clinicaltrials.gov, controlled-trials.com, and relevant grey literature were used to search for original research articles, and reference lists of included articles were then hand searched.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sixty-four studies were included in the review: 52 animal studies and 12 human studies. Studies used a variety of preclinical paradigms and questionnaires to assess change in mood, and few studies examined sleep or cognition. Forty-four out of 47 (44\/47) preclinical 5-HT7 modulation studies identified potential antidepressant effects and 20\/23 studies identified potential anxiolytic effects. In clinical studies, 5\/7 identified potential antidepressant effects in major depressive disorder, 1\/2 identified potential anxiolytic effects in generalized anxiety disorder, and 3\/3 identified potential antidepressant effects in bipolar disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>While there is some evidence that the 5-HT7 receptor system may be a potential target for treating mood and anxiety disorders, many agents included in the review also bind to other receptors. Further research is needed using drugs that bind specifically to 5-HT7 receptors to examine treatment proof of concept further.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811231211228","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T07:24:40Z","timestamp":1700724280000},"page":"1167-1181","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":35,"title":["The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9220-1234","authenticated-orcid":false,"given":"Natalie","family":"Gottlieb","sequence":"first","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul RA","family":"Stokes","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1521-8."},{"key":"e_1_3_3_3_1","first-page":"900","article-title":"Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety","volume":"13","author":"Adell A","year":"2010","unstructured":"Adell A (2010) Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety. IDrugs 13: 900\u2013910.","journal-title":"IDrugs"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.09.012."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001027."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2010.01516.x."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.09.006."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.115.3.245."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2018.12.019."},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283530ad7."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)49479-9"},{"key":"e_1_3_3_12_1","first-page":"21","article-title":"Lurasidone: A new treatment option for bipolar depression\u2014A review","volume":"12","author":"Bawa R","year":"2015","unstructured":"Bawa R, Scarff JR (2015) Lurasidone: A new treatment option for bipolar depression\u2014A review. Innov Clin Neurosci 12: 21\u201323.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.193995."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.119404."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.178."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.11.009."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000135120."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.3791\/3769."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.11.040."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.12.041."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.11.041."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.03.057."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3639-6."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.01.023."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(13)70960-5."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12698."},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.64719\/pb.4597","article-title":"Asenapine in the treatment of bipolar depression","volume":"50","author":"El-Mallakh RS","year":"2020","unstructured":"El-Mallakh RS, Nuss S, Gao D, et al (2020) Asenapine in the treatment of bipolar depression. Psychopharmacol Bull 50: 8\u201318.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9152-z."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000201934."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-894x(02)00690-x."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0973-y"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2013-0066."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.12.020."},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126703."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.11.007."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.12.063."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.05.014."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.11.015"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703357."},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x."},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S68417."},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.05.012"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.12.054"},{"key":"e_1_3_3_45_1","first-page":"543","article-title":"NETWATCH","volume":"287","author":"Helmuth L","year":"2000","unstructured":"Helmuth L (2000) NETWATCH. Science 287, 543\u2013543.","journal-title":"Science"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07470."},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2013.01.026."},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09335."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112437."},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980519u"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2014.07.026."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.01.043."},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12509."},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.093."},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.02.003."},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.22059."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049702f."},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800615e."},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2013.09.002."},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070984."},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273%2893%2990149-L."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.761600."},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09337."},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705576."},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2018.11.019."},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145714000546."},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.280"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500880c."},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.13."},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382."},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.189068."},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9736.1."},{"key":"e_1_3_3_73_1","first-page":"25","article-title":"Behavioral characteristics of SM-13496, a novel atypical antipsychotic agent","volume":"57","author":"Ohno Y","year":"1997","unstructured":"Ohno Y, Ishibashi T, Tokuda K, et al (1997) Behavioral characteristics of SM-13496, a novel atypical antipsychotic agent. Acta Neurobiol Exp (Warsz.) 57: 25.","journal-title":"Acta Neurobiol Exp (Warsz.)"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4."},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71."},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2018.10.004."},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.04.046."},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1998.tb10044.x"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9932-9."},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0605-4."},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.06.032."},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142499."},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/107385840000600408."},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.07.011."},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.18.8547."},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(02)01866-8."},{"key":"e_1_3_3_87_1","volume-title":"Presented at the Proceedings of the 14th camerino-noordwijkerhout symposium: Ongoing progress in the receptor chemistry","author":"Sanin A","year":"2004","unstructured":"Sanin A, Brisander M, Rosqvist S, et al (2004) 5-aryl substituted (S)-2-(dimethylamino)-tetralins novel serotonin 5-HT7 ligands. In: Presented at the Proceedings of the 14th camerino-noordwijkerhout symposium: Ongoing progress in the receptor chemistry, Camerino, Italy, 7\u201311 September 2003, p. 24."},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.105002."},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.10.003."},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15060770."},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.2.022305.095301."},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2004.04006.x."},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705290."},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702759."},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb16327.x."},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm070279v."},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200547z."},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126769."},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.12394."},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.09.064"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.04.017"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.10.001"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111736."},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.3791\/52587."},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429."},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2016.1198902."},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.04.046."},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5MD00166H."},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2012.07.043."},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2012.11.042."},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.09.044."},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.12.039."},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12141."},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.606."}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231211228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811231211228","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231211228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:33Z","timestamp":1777507893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811231211228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":113,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1177\/02698811231211228"],"URL":"https:\/\/doi.org\/10.1177\/02698811231211228","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}